240 related articles for article (PubMed ID: 22986058)
1. Identification of BACE2 as an avid ß-amyloid-degrading protease.
Abdul-Hay SO; Sahara T; McBride M; Kang D; Leissring MA
Mol Neurodegener; 2012 Sep; 7():46. PubMed ID: 22986058
[TBL] [Abstract][Full Text] [Related]
2. BACE2 degradation mediated by the macroautophagy-lysosome pathway.
Liu X; Wang Z; Wu Y; Wang J; Song W
Eur J Neurosci; 2013 Jun; 37(12):1970-7. PubMed ID: 23773066
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease.
Nalivaeva NN; Fisk LR; Belyaev ND; Turner AJ
Curr Alzheimer Res; 2008 Apr; 5(2):212-24. PubMed ID: 18393806
[TBL] [Abstract][Full Text] [Related]
4. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes.
Sun X; Wang Y; Qing H; Christensen MA; Liu Y; Zhou W; Tong Y; Xiao C; Huang Y; Zhang S; Liu X; Song W
FASEB J; 2005 May; 19(7):739-49. PubMed ID: 15857888
[TBL] [Abstract][Full Text] [Related]
5. BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells.
Rochin L; Hurbain I; Serneels L; Fort C; Watt B; Leblanc P; Marks MS; De Strooper B; Raposo G; van Niel G
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10658-63. PubMed ID: 23754390
[TBL] [Abstract][Full Text] [Related]
6. Effect of Global Brain Ischemia on Amyloid Precursor Protein Metabolism and Expression of Amyloid-Degrading Enzymes in Rat Cortex: Role in Pathogenesis of Alzheimer's Disease.
Babusikova E; Dobrota D; Turner AJ; Nalivaeva NN
Biochemistry (Mosc); 2021 Jun; 86(6):680-692. PubMed ID: 34225591
[TBL] [Abstract][Full Text] [Related]
7. BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease.
Barão S; Moechars D; Lichtenthaler SF; De Strooper B
Trends Neurosci; 2016 Mar; 39(3):158-169. PubMed ID: 26833257
[TBL] [Abstract][Full Text] [Related]
8. BACE2: A Promising Neuroprotective Candidate for Alzheimer's Disease.
Yeap YJ; Kandiah N; Nizetic D; Lim KL
J Alzheimers Dis; 2023; 94(s1):S159-S171. PubMed ID: 36463454
[TBL] [Abstract][Full Text] [Related]
9. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
10. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
Vassar R
J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
[TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens.
Li G; Percontino L; Sun Q; Qazi AS; Frederikse PH
Mol Vis; 2003 May; 9():179-83. PubMed ID: 12740567
[TBL] [Abstract][Full Text] [Related]
12. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
[TBL] [Abstract][Full Text] [Related]
13. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain.
Wang S; Wang R; Chen L; Bennett DA; Dickson DW; Wang DS
J Neurochem; 2010 Oct; 115(1):47-57. PubMed ID: 20663017
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice.
Shimshek DR; Jacobson LH; Kolly C; Zamurovic N; Balavenkatraman KK; Morawiec L; Kreutzer R; Schelle J; Jucker M; Bertschi B; Theil D; Heier A; Bigot K; Beltz K; Machauer R; Brzak I; Perrot L; Neumann U
Sci Rep; 2016 Feb; 6():21917. PubMed ID: 26912421
[TBL] [Abstract][Full Text] [Related]
15. BACE1 and BACE2 enzymatic activities in Alzheimer's disease.
Ahmed RR; Holler CJ; Webb RL; Li F; Beckett TL; Murphy MP
J Neurochem; 2010 Feb; 112(4):1045-53. PubMed ID: 19968762
[TBL] [Abstract][Full Text] [Related]
16. A series of molecular modeling techniques to reveal selective mechanisms of inhibitors to β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) and β-site amyloid precursor protein cleaving enzyme 2 (BACE2).
Li S; Zhao H; Li J; Hao J; Yu H
J Biomol Struct Dyn; 2021 May; 39(8):2824-2837. PubMed ID: 32276567
[TBL] [Abstract][Full Text] [Related]
17. Beta-secretase (BACE) as a drug target for Alzheimer's disease.
Vassar R
Adv Drug Deliv Rev; 2002 Dec; 54(12):1589-602. PubMed ID: 12453676
[TBL] [Abstract][Full Text] [Related]
18. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
Stockley JH; O'Neill C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655
[TBL] [Abstract][Full Text] [Related]
19. Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer's Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers.
Huentelman M; De Both M; Jepsen W; Piras IS; Talboom JS; Willeman M; Reiman EM; Hardy J; Myers AJ
Sci Rep; 2019 Jul; 9(1):9640. PubMed ID: 31270419
[TBL] [Abstract][Full Text] [Related]
20. BACE2 beyond β-processing of APP, its neuroprotective role in cerebrovascular endothelium.
Sáez-Valero J; Pérez-González R
J Neurochem; 2023 Sep; 166(6):887-890. PubMed ID: 37587672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
